On August 27, 2021, in a Federal Register Notice, the Office of the U.S. Trade Representative (USTR) issued a request for comments on extending the exclusions for certain product descriptions under Section 301. The exclusions are for “certain medical-care products needed to address the COVID-19 pandemic.” The exclusions are currently scheduled to expire on September 30, 2021. Comments on the extension should be submitted by September 27, 2021.
Details for comment submission can be found in the Federal Register Notice here: